Tesla hits technical target at $610, traders may look to buy on dips

Readers could consider buying on short-term dips as long as the 50-day EMA continues to provide support

Tech (1)

For those who follow such things, the “World’s Richest People” list has seen a dramatic shakeup this year. Many of the familiar names (Bezos, Gates, Arnault, Zuckerberg, Buffett, etc) remain in the Top 10, but Tesla’s eccentric CEO Elon Musk has seen his wealth balloon to nearly $150B on the back of the huge rally in TSLA stock to propel him all the way up to #2 overall. With TSLA (finally) set to be formally added to the S&P 500 before markets open on 21 December, what are the prospects for the hotly-debated electric automaker moving forward?

From a fundamental perspective, Tesla is the quintessential growth stock. In other words, the company has low revenue and profit figures relative to its current price, with traders more focused on the firm’s future prospects and total addressable market. Based on analysts’ estimates for the next twelve months, TSLA sports a P/E ratio of 160 and P/S ratio of 13; by way of comparison, Tesla’s valuation is ~25X higher than the equivalent ratios for General Motors (GM), a far more established and profitable automaker, at 6.7 and 0.5 respectively.

Turning to the chart, the only thing more incredible than Tesla’s sky-high valuation ratios is the strength of its current uptrend. Since bottoming near $70 in mid-March, TSLA has surged nearly 800% to trade above $620. The most relevant technical features of the chart are the 50-day exponential moving average, which has consistently provided support over the past nine months, and the bullish pennant formation from September and October. The mid-November breakout from that pattern created a “measured move” price objective near $610:

Source: TradingView, GAIN Capital

With prices reaching that technical objective this morning and trading well above the 50-day EMA, it wouldn’t be surprising to see the stock pause or pullback into the $500s in the coming days. That said, TSLA remains in a strong uptrend, and with many funds trying to “window dress” their portfolios ahead of end-of-year communications, readers could consider buying on short-term dips as long as the 50-day EMA continues to provide support.

After all, Elon Musk becoming the richest person on the planet seems like an oddly apropos development for the bizarre, unprecedented year we’ve lived through thus far!


Build your confidence risk free

More from Tech Stocks

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.